Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
LINCOLN INTERNATIONAL LLC (LCLN)
NYSEFinancialsFinancial - Capital MarketsSnapshot 2026-11-04
$26.83-1.54%
Close 2026-11-05 · 1-day change
NYSEFinancialsFinancial - Capital MarketsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 4, 2026.
Next-FY EPS estimate change · 30 days
1.83 → 1.75 EPS · FY ending Dec 31, 2027 · 4 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 4 to 4; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for LCLN yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Debt reduction from IPO proceeds | A supporting condition in LINCOLN INTERNATIONAL LLC's published investment case. The stated target is reduce debt to $100 million. | Intact | debt exceeds $100 million next year | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 1 supplied quarters. Management reported: “During the second quarter, the Company used a portion of the net proceeds from its initial public offering to repay approximately $195.8 million of the debt incurred primarily to finance the MarshBerry acquisition, further strengthening its balance sheet and enhancing financial flexibility.” “The Board of Directors declared a quarterly cash dividend of $0.07 per share of Class A common stock, payable on September 15, 2026, to Class A common stockholders of record as of September 1, 2026.” |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 5, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a financial-services growth story, with expansion tied to mergers and acquisitions and a broader mix of advisory work. The thesis is mixed: management is delivering on growth and debt reduction, but recent company momentum has declined and the available evidence is not enough to judge the broader thesis state.
The evidence does not provide a valuation level or a clear account of what investors already expect, so it is not possible to describe LCLN as cheap, fair, or expensive versus peers. Fragility is rated low, but that does not establish the size of the expectations gap.
In the near term, recent results showed strong revenue growth, led by investment banking advisory and valuations and opinions, and management says growth execution is on track. The company also reduced long-term debt after its IPO, while talent investment is mixed; momentum has fallen, and a past deep miss plus smaller-company status are reasons for caution despite a low estimated miss probability.
For the multi-year thesis, continued growth in advisory services and disciplined execution matter, along with progress in developing talent and allocating capital. Near term, a guidance cut would be a meaningful negative, while continued strong results and higher guidance from sector peers could support sector momentum; rate cuts are another stated risk.
Over the next 1 to 3 years, LCLN’s business case has support from revenue growth and lower debt, but weaker momentum and limited evidence on valuation leave important questions open. The thesis depends on sustained execution and how near-term guidance, rates, and sector conditions develop. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Earnings per share growth | It earned $0.26 per share last quarter. | Intact | falls below $0.65 EPS next quarter | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth from M&A and advisory services | A primary condition in LINCOLN INTERNATIONAL LLC's published investment case. The stated target is >=20% YoY. | Intact | falls below 20% YoY revenue growth next year | Required source inputs unavailable Cannot calculate Revenue growth from the available matching source inputs. Missing inputs are not treated as zero. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 1 supplied quarters. Management reported: “Investment Banking Advisory revenues were $177.7 million for the second quarter, a 56% increase from the prior-year period primarily due to a higher number of transactions completed, higher average fees and our acquisition of MarshBerry.” “Valuations and Opinions revenues were $47.9 million for the second quarter, a 35% increase from the prior-year period primarily driven by increasing demand for portfolio valuations and transaction opinions.” Revenue was $225.693 million in 2026-Q2. Delivery assessment Nov 4, 2026 |
Stored thesis · Oct 4, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.75 → $1.75 · observed estimates
$1.13B → $1.13B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-27 | $1.75 | $1,130,000,000 | 4 / 5 |
| 2026-07-28 | $1.75 | $1,130,000,000 | 4 / 5 |
| 2026-07-29 | $1.71 | $1,100,524,880 | 7 / 7 |
| 2026-07-30 | $1.71 | $1,100,524,880 | 7 / 7 |
| 2026-07-31 | $1.71 | $1,100,524,880 | 7 / 7 |
| 2026-08-01 | $1.75 | $1,130,000,000 | 4 / 5 |
| 2026-08-02 | $1.75 | $1,130,000,000 | 4 / 5 |
| 2026-08-03 | $1.75 | $1,130,000,000 | 4 / 5 |
| 2026-08-04 | $1.71 | $1,100,524,880 | 7 / 7 |
| 2026-08-05 | $1.71 | $1,100,524,880 | 7 / 7 |
| 2026-08-06 | $1.71 | $1,100,524,880 | 7 / 7 |
| 2026-08-07 | $1.75 | $1,130,000,000 | 4 / 5 |
| 2026-08-08 | $1.75 | $1,130,000,000 | 4 / 5 |
| 2026-08-09 | $1.75 | $1,130,000,000 | 4 / 5 |
| 2026-08-10 | $1.72 | $1,136,245,180 | 7 / 7 |
| 2026-08-12 | $1.72 | $1,136,245,180 | 7 / 7 |
| 2026-08-13 | $1.75 | $1,130,000,000 | 4 / 5 |
| 2026-08-14 | $1.75 | $1,130,000,000 | 4 / 5 |
| 2026-08-15 | $1.75 | $1,130,000,000 | 4 / 5 |
| 2026-08-16 | $1.75 | $1,130,000,000 | 4 / 5 |
| 2026-08-17 | $1.75 | $1,130,000,000 | 4 / 5 |
| 2026-08-18 | $1.75 | $1,130,000,000 | 4 / 5 |
| 2026-08-19 | $1.75 | $1,130,000,000 | 4 / 5 |
| 2026-08-20 | $1.75 | $1,130,000,000 | 4 / 5 |
| 2026-08-21 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-08-22 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-08-23 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-08-24 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-08-25 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-08-26 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-08-27 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-08-28 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-08-29 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-08-30 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-08-31 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-01 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-02 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-03 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-04 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-05 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-06 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-07 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-08 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-09 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-10 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-11 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-12 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-13 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-14 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-15 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-16 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-17 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-18 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-19 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-20 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-21 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-22 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-23 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-24 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-25 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-26 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-27 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-28 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-29 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-09-30 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-10-01 | $1.83 | $1,160,000,000 | 4 / 5 |
| 2026-10-02 | $1.83 | $1,160,000,000 | 4 / 4 |
| 2026-10-03 | $1.83 | $1,160,000,000 | 4 / 4 |
| 2026-10-04 | $1.83 | $1,160,000,000 | 4 / 4 |
| 2026-10-05 | $1.83 | $1,160,000,000 | 4 / 4 |
| 2026-10-06 | $1.83 | $1,160,000,000 | 4 / 4 |
| 2026-10-07 | $1.83 | $1,160,000,000 | 4 / 4 |
| 2026-10-08 | $1.83 | $1,160,000,000 | 4 / 4 |
| 2026-10-09 | $1.83 | $1,160,000,000 | 4 / 4 |
| 2026-10-10 | $1.83 | $1,160,000,000 | 4 / 4 |
| 2026-10-11 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-10-12 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-10-13 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-10-14 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-10-15 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-10-16 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-10-17 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-10-18 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-10-19 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-10-20 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-10-21 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-10-22 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-10-23 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-10-24 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-10-25 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-10-26 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-10-27 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-10-28 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-10-29 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-10-30 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-10-31 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-11-01 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-11-02 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-11-03 | $1.75 | $1,130,000,000 | 4 / 4 |
| 2026-11-04 | $1.75 | $1,130,000,000 | 4 / 4 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 3 Buy / Strong Buy · 4 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 1 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.